172 related articles for article (PubMed ID: 28431393)
21. PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells.
Vidal LJ; Perry JK; Vouyovitch CM; Pandey V; Brunet-Dunand SE; Mertani HC; Liu DX; Lobie PE
Mol Cancer Res; 2010 Mar; 8(3):444-56. PubMed ID: 20197384
[TBL] [Abstract][Full Text] [Related]
22. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
23. ER/Golgi trafficking is facilitated by unbranched actin filaments containing Tpm4.2.
Kee AJ; Bryce NS; Yang L; Polishchuk E; Schevzov G; Weigert R; Polishchuk R; Gunning PW; Hardeman EC
Cytoskeleton (Hoboken); 2017 Oct; 74(10):379-389. PubMed ID: 28834398
[TBL] [Abstract][Full Text] [Related]
24. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients.
Savill SA; Leitch HF; Harvey JN; Thomas TH
PLoS One; 2016; 11(9):e0162908. PubMed ID: 27649540
[TBL] [Abstract][Full Text] [Related]
26. Actin cytoskeleton participation in the onset of IL-1beta induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 cells.
Franco-Barraza J; Valdivia-Silva JE; Zamudio-Meza H; Castillo A; García-Zepeda EA; Benítez-Bribiesca L; Meza I
Arch Med Res; 2010 Apr; 41(3):170-81. PubMed ID: 20682174
[TBL] [Abstract][Full Text] [Related]
27. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
28. MASTL promotes cell contractility and motility through kinase-independent signaling.
Taskinen ME; Närvä E; Conway JRW; Hinojosa LS; Lilla S; Mai A; De Franceschi N; Elo LL; Grosse R; Zanivan S; Norman JC; Ivaska J
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32311005
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide and protein sequences for dog masticatory tropomyosin identify a novel Tpm4 gene product.
Brundage EA; Biesiadecki BJ; Reiser PJ
J Muscle Res Cell Motil; 2015 Oct; 36(4-5):339-347. PubMed ID: 26400443
[TBL] [Abstract][Full Text] [Related]
30. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
32. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
33. The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression.
Caporali S; Calabrese C; Minieri M; Pieri M; Tarantino U; Marini M; D'Ottavio S; Angeletti S; Mauriello A; Cortese C; Bernardini S; Terrinoni A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575979
[TBL] [Abstract][Full Text] [Related]
34. The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility.
Menhofer MH; Kubisch R; Schreiner L; Zorn M; Foerster F; Mueller R; Raedler JO; Wagner E; Vollmar AM; Zahler S
PLoS One; 2014; 9(11):e112542. PubMed ID: 25391145
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
36. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance and biological function of tropomyosin 4 in colon cancer.
Yang R; Zheng G; Ren D; Chen C; Zeng C; Lu W; Li H
Biomed Pharmacother; 2018 May; 101():1-7. PubMed ID: 29455030
[TBL] [Abstract][Full Text] [Related]
38. Load-dependent modulation of non-muscle myosin-2A function by tropomyosin 4.2.
Hundt N; Steffen W; Pathan-Chhatbar S; Taft MH; Manstein DJ
Sci Rep; 2016 Feb; 6():20554. PubMed ID: 26847712
[TBL] [Abstract][Full Text] [Related]
39. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
40. Unraveling the Role of Huntingtin in Breast Cancer Metastasis.
Thion MS; McGuire JR; Sousa CM; Fuhrmann L; Fitamant J; Leboucher S; Vacher S; du Montcel ST; Bièche I; Bernet A; Mehlen P; Vincent-Salomon A; Humbert S
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26293574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
